In Brazil Market for Breast Cancer Drugs to Grow 40% in 4 Years

Cancer treatment The breast cancer drug market in Brazil will grow from US$ 424 million in 2009 to US$ 611 million in 2014, says Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues.

Factors promoting the market’s growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.

“The value of the Brazilian breast cancer drug market in 2009 (US$ 424 million) rivals those in some major pharmaceutical markets like United Kingdom and Japan and greatly exceeds breast cancer drug sales in other emerging markets (China, India, Russia),” stated Decision Resources’ Therapeutic Area Director Kate Hohenberg.

“A well-established public healthcare system that pays the cost of drug therapy for eligible patients and a small but lucrative pool of privately insured patients support Brazil’s sizeable breast cancer drug  market.”

The new Emerging Markets report entitled Breast Cancer in Brazil also finds that given the drawbacks and limitations of current treatments and Brazilian physicians’ enthusiasm for novel approaches in hard-to-treat patient segments (e.g., triple-negative breast cancer), emerging breast cancer therapies will be well received in Brazil.

Two novel agents – Roche’s trastuzumab-DM1 and Sanofi-Aventis’s BSI-201 – are expected to launch in Brazil towards the end of 2014.

“By the end of our five-year forecast period (2009-2014), we expect two novel breast cancer agents to launch in Brazil – Roche’s trastuzumab-DM1 and Sanofi-Aventis’s BSI-201. These launches will be facilitated by the low regulatory hurdle (additional domestic clinical trials are not required) and physicians’ receptivity to new therapies for underserved segments of the breast cancer market,” added Ms. Hohenberg.

The new reports features extensive primary research of physicians and epidemiology study, with analysis of trends in major Brazilian cities – Rio de Janeiro, São Paulo, Brasília, Belo Horizonte, Curitiba and Salvador – and the country overall.

Tags:

  • Show Comments (1)

  • eco plaques

    That’s good to hear. More help for those in need.

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

The WTO Battle Lost, Can Brazil Still Win the War?

In a statement made last week by Foreign Minister Celso Amorim, Brazil has withdrawn ...

RAPIDINHAS

A Soul Portrait Once a central port in the Portuguese colonial network of commerce ...

Brazilians Say No to Disarmament

The number of Brazilians who favor prohibiting weapons sales in the country plummeted from ...

Brazil Program Readies Small Businesses to Sell Overseas

Brazilian micro and small industries are already harvesting the fruit of a program whose ...

Picasso, Matisse, Dali and Monet Stolen at Gunpoint in Brazil

Four armed men entered the Chácara do Céu Museum, in the Santa Teresa district ...

Viacabo Brazil Offers New PPV Technology

Norway-based Conax AS has launched a pilot of its new Conax CAS7 modular system ...

Brazil Ups Scientific Production and Is Ahead of the Swiss and Swedish

Brazilian scientists have jumped to 15th position worldwide in scientific production. With 19,428 articles ...

Brazilian Plastic Industry Exports Fall 15%

The plastics industry in Brazil earned US$ 1.1 billion from exports of processed plastic ...

Brazil Praises Choice of Haiti’s New President and Says It Didn’t Interfere

The Brazilian government commended the way the Haitian general elections have been handled after ...

Tupi or not Tupi or Only Cannibalism Unites Us Brazilians

“Every Brazilian, even the light skinned fair haired one carries about him on his ...